These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4017267)

  • 1. Observations on the "cascade" of Na-K-ATPase inhibitory and digoxin-like immunoreactive material in human urine: possible relevance to essential hypertension.
    Weiler E; Tuck M; Gonick HC
    Clin Exp Hypertens A; 1985; 7(5-6):809-36. PubMed ID: 4017267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC; Weiler EW; Prins BA; Purdy RE
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine.
    Clarkson EM; de Wardener HE
    Clin Exp Hypertens A; 1985; 7(5-6):673-83. PubMed ID: 2990768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of Na-K-ATPase inhibitors in plasma and urine of hypertensive patients: a preliminary report.
    Gonick HC; Weiler E; Khalil-Manesh F
    Klin Wochenschr; 1987; 65 Suppl 8():139-45. PubMed ID: 3599799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
    Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
    Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous inhibition of red blood cell Na,K-ATPase in essential and pregnancy-induced hypertension.
    Ringel R; Pinkas G; Hamlyn J; Mullins L; Hamilton B
    Clin Exp Hypertens A; 1989; 11(4):587-601. PubMed ID: 2551544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
    Graves SW; Lincoln K; Cook SL; Seely EW
    Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of endogenous Na+,K+-ATPase inhibitors in human plasma and urine using high-performance liquid chromatography.
    Crabos M; Wainer IW; Cloix JF
    FEBS Lett; 1984 Oct; 176(1):223-8. PubMed ID: 6208054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ouabain-like Na+,K(+)-ATPase inhibitory activity of a plasma extract in normal pregnancy and pregnancy induced hypertension.
    Miyagi H; Higuchi M; Nakayama M; Moromizato H; Sakanashi M
    Jpn J Pharmacol; 1991 Dec; 57(4):571-81. PubMed ID: 1666421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
    Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
    Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Meyer P
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1522-7. PubMed ID: 2825938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertension.
    Gonick HC; Weiler EW; Khalil-Manesh F; Weber MA
    Am J Hypertens; 1993 Aug; 6(8):680-7. PubMed ID: 8217031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
    De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
    Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ; Baecker A; Weiler E; Liddiard C
    Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertension.
    Seccombe DW; Pudek MR; Nowaczynski W; Humphries KH
    Clin Biochem; 1989 Feb; 22(1):17-21. PubMed ID: 2539926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma digoxin immunoreactivity and arterial potassium relaxation after quinapril therapy in hypertensive rats.
    Kähönen M; Doris PA; Mäkynen H; Pörsti I
    J Pharmacol Exp Ther; 1995 Nov; 275(2):832-7. PubMed ID: 7473173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.